First clinical studies investigated CAR T-cells directed against Lewis Y antigen (7), CD19 (8), CD138 (9), and free light chain (10) in patients with relapsed/refractory (RR) MM. This evidence concerns the gene SDC1 and Miyoshi myopathy.